Results 11 to 20 of about 63,194 (248)
American Journal of Medical Genetics Part A, Volume 191, Issue 2, Page 445-458, February 2023., 2023 Abstract Chromosome 1p36 deletion syndrome (1p36DS) is one of the most common terminal deletion syndromes (incidence between 1/5000 and 1/10,000 live births in the American population), due to a heterozygous deletion of part of the short arm of chromosome 1.
Clémence Jacquin +47 more
wiley +1 more source
Describing and Classifying Shock: Recent Insights
US Cardiology Review, 2021 Cardiogenic shock continues to present a daunting challenge to clinicians, despite an increasing array of percutaneous mechanical circulatory support devices. Mortality for cardiogenic shock has not changed meaningfully in more than 20 years.
Ashleigh Long +3 more
doaj +1 more source
Catheterization and Cardiovascular Interventions, Volume 100, Issue 7, Page 1159-1170, December 1, 2022., 2022 Abstract Background Clinical factors favouring coronary angiography (CA) selection and variables associated with in‐hospital mortality among patients presenting with out‐of‐hospital cardiac arrest (OHCA) without ST‐segment elevation (STE) remain unclear.
Wayne C. Zheng +15 more
wiley +1 more source
A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock
Clinical Medicine Insights: Cardiology, 2022 This is a focused review looking at the pharmacological support in cardiogenic shock. There are a plethora of data evaluating vasopressors and inotropes in septic shock, but the data are limited for cardiogenic shock.
Aditi Shankar +6 more
doaj +1 more source
Practical aspects of managing patients with cardiogenic shock
Российский кардиологический журнал, 2023 Cardiogenic shock is the leading cause of death among patients with acute coronary syndrome. This pathology is characterized by high rates of inhospital and annual mortality.
M. M. Novosadov +3 more
doaj +1 more source
ESC Heart Failure, 2021 Cardiogenic shock (CS) portends high morbidity and mortality in the contemporary era. Despite advances in temporary mechanical circulatory supports (MCS), their routine use in CS to improve outcomes has not been established.
Nima Moghaddam +4 more
doaj +1 more source
Cardiogenic shock - novelty and emerging therapeutic concepts [PDF]
Българска кардиология, 2022 The cardiogenic shock is a state of low cardiac output, primarily due to cardiac dysfunction, which leads to severe organ hypoperfusion with tissue hypoxia and increased lactate levels. It presents a severe complication with a prevalence of around 15% of
I. Petrov, Z. Stankov, S. Vasilev
doaj +3 more sources
Microcirculatory dysfunction in cardiogenic shock
Annals of Intensive Care, 2023 Cardiogenic shock is usually defined as primary cardiac dysfunction with low cardiac output leading to critical organ hypoperfusion, and tissue hypoxia, resulting in high mortality rate between 40% and 50% despite recent advances.
Hamid Merdji +5 more
doaj +1 more source
Clinical Cardiology, Volume 45, Issue 12, Page 1264-1271, December 2022., 2022 Abstract Background Severe atherosclerosis of the ascending aorta (SAA) in patients undergoing surgical revascularization by coronary artery bypass grafting (CABG) is becoming an increasing problem as more elderly patients are diagnosed with coronary artery disease.
Rakan I. Nazer, Ali M. Albarrati
wiley +1 more source
Актуальні проблеми сучасної медицини, 2020 Cardiogenic shock is the leading cause of death in patients with acute myocardial infarction, with high hospital mortality rates ∼80 %. The incidence of cardiogenic shock among myocardial infarction patients is approximately 7 %.
Olena Makharynska +3 more
doaj +1 more source